Interserve has been chosen to deliver an “ultra modern radiotherapy centre” at Colchester General Hospital.
The development is planned to replace the current centre at Essex County Hospital, incorporating five ‘bunkers’.
Three linear accelerators will be installed initially, with a further two to be fitted out later as demand is expected to rise.
Interserve regional manager Chris Mardell said: “We are delighted to be appointed by Colchester Hospital University NHS Foundation Trust, and look forward to continuing the excellent working relationship we have established with the Trust and other stakeholders to deliver this important project.
“The new building, which is a centre of excellence for cancer treatment incorporating the most up-to-date radiotherapy machines, will provide a first-class environment for patients and carers. Through this scheme we will strengthen our existing links with the county, and create opportunities for the local supply chain to benefit from the project.”
Interserve, Devereux Architects, the NHS trust and clinical staff and users all played roles in the centre’s design.
Interserve’s Cambridge office will manage the build, supported by Arup Services and Structural Design, Gleeds Cost Management Interserve Engineering Services. The centre will represent Colchester Health Service’s biggest single capital investment since the General Hospital was built in the 80s.
Colchester University NHS Foundation Trust CEO Dr Gordon Coutts said: “This is fantastic news for the Trust, but particularly for the adult population of north east and mid Essex for whom we provide radiotherapy services.
“The radiotherapy department at Essex County Hospital continues to provide an outstanding service, but it has long been this organisation’s plan to centralise cancer services on the site of Colchester General Hospital. We will be able to put in the most up-to-date machines and provide a quality service in a first-class environment for patients and carers.”
The build is expected to be completed next year, starting treatments in early 2014.